Bleeding-Linked Hospitalization Up With Amiodarone in A-Fib
TUESDAY, May 23, 2023 -- For patients with atrial fibrillation receiving apixaban or rivaroxaban, the risk of bleeding-related hospitalizations is greater during amiodarone treatment than flecainide or sotalol, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 23, 2023 Category: Pharmaceuticals Source Type: news

Community pharmacy quality scheme: high risk medicines audit
This report details the results and findings of the 2019/20 high risk medicines audit report for lithium, methotrexate, amiodarone and phenobarbital and makes recommendations on further actions. (Source: NHS Networks)
Source: NHS Networks - March 21, 2023 Category: UK Health Source Type: news

FDA Drug Safety Communication: Connection problems involving certain needleless pre-filled glass syringes containing adenosine and amiodarone
[05-06-2011] The U.S. Food and Drug Administration (FDA) is alerting the healthcare community about syringe connection problems when certain needleless glass syringes containing the cardiac drugs adenosine and amiodarone are used with particular types of intravenous (IV) access systems. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Late-Breaking Phase 3 A DUE Data Show Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil Significantly Improves Pulmonary Hemodynamics versus Monotherapy in Patients with Pulmonary Arterial Hypertension (PAH)
RARITAN, NJ, March 6, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 3 A DUE study (NCT03904693), which showed an investigational once-daily, single tablet combination therapy, also known as fixed dose combination, of macitentan 10 mg and tadalafil 40 mg (M/T STCT), significantly improved pulmonary hemodynamics (blood flow through pulmonary blood vessels) versus macitentan and tadalafil monotherapies in pulmonary arterial hypertension (PAH) patients with World Health Organization (WHO) functional class (FC) II or III.[1] The data were presented today as a Late-...
Source: Johnson and Johnson - March 6, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Janssen Showcases Commitment to Advancing Scientific Innovation in Pulmonary Arterial Hypertension (PAH) at CHEST 2021 Annual Meeting
TITUSVILLE, N.J. – October 14, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 11* abstracts highlighting data from its pulmonary hypertension (PH) portfolio will be presented at CHEST 2021, the annual meeting of the American College of Chest Physicians, held virtually October 17-20.Data presentations from eight abstracts will provide additional evidence supporting the role of objective multiparameter risk assessment approaches in helping to optimize treatment and care for pulmonary arterial hypertension (PAH), as well as the impact of earlier and comprehensive therapy with UPTRAVI...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

First case of acute poisoning with amiodarone and flecainide in attempted suicide successfully managed with lipid emulsion therapy in the emergency department: case report and literature review - Bologa C, Lionte C, Popescu A, Sorodoc V, Sorodoc L.
We report a 47-year-old patient admitted to the ED 5 h after... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein Inhibitors, Clinical Infectious Diseases
This case report describes a critically-ill patient with Covid-19 who developed hepatotoxicity 5 days after Remdesivir was started; rapid decreases in ALT and AST were seen upon its discontinuation. An interaction with Amiodarone (started 2 days after Remdesivir) is proposed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 22, 2021 Category: Consumer Health News Source Type: news

ECG Challenge:'I'm Having Trouble Breathing'ECG Challenge:'I'm Having Trouble Breathing '
A man taking amiodarone for his atrial fibrillation feels increasingly short of breath and visits the emergency department. What ' s the diagnosis?Medscape Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2021 Category: Consumer Health News Tags: Cardiology Clinical Case Source Type: news

Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up
Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl Injection, USP 450 mg/9 mL, packaged in cartons of 10 single-dose 9 mL vials and Tranexamic Acid Injec (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 31, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Unichem Laboratories gets USFDA nod for drug to treat irregular heartbeat
Drug firm Unichem Laboratories on Wednesday said it has received approval from the US health regulator for its Amiodarone tablets used to treat irregular heartbeat. The approved product is a generic version of Wyeth Pharmaceuticals Inc's Cordarone tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2020 Category: Pharmaceuticals Source Type: news

Amiodarone HCl Injection (Amiodarone HCl Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 4, 2019 Category: Drugs & Pharmacology Source Type: news

Digoxin vs. amiodarone
Title: Digoxin vs. amiodaroneCategory: MedicationsCreated: 7/30/2019 12:00:00 AMLast Editorial Review: 7/30/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 30, 2019 Category: Drugs & Pharmacology Source Type: news

Pacerone (Amiodarone HCl Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 12, 2019 Category: Drugs & Pharmacology Source Type: news

amiodarone, Cordarone, Nextrone, Pacerone
Title: amiodarone, Cordarone, Nextrone, PaceroneCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/2/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 2, 2019 Category: Cardiology Source Type: news

Baxter Issues A Voluntary Nationwide Recall For One Lot of Nexterone Injection Due To Presence Of Particulate Matter
Baxter International Inc. announced today it is voluntarily recalling one lot of NEXTERONE (amiodarone HCl) 150 mg/100 mL Premixed Injection – distributed between 6/23/2017 and 10/2/2017 in the United States to wholesalers/distributors and healthcare facilities – due to the potential presence of particulate matter. The particulate matter may have entered the solution during the manufacturing process. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 30, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news